DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Piramal Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·29 Jul 2026, 3:24 pm

Piramal Pharma

Piramal Pharma Limited has informed stock exchanges about its upcoming presentation at an institutional investor meet. This event is likely to be a platform for the company to discuss its strategic roadmap, recent business developments, and future outlook with analysts and investors.

For investors, such updates are significant as they provide direct insight into management’s thinking. It offers a chance to understand how the company plans to navigate the current market environment and execute its growth strategies.

Investors should watch for key announcements regarding new product launches, acquisitions, or guidance on financial performance during the presentation.